Skip to main content

Find Eczema-Friendly Products Find a Doctor

About Eczema

Research

Get Involved

About Us

generic image

Press Releases

Read the latest news, statements and announcements from the National Eczema Association.

Home
Press release

Latest

beside text image

NEA Awards 9 Grants for Eczema Research

March 19, 2026

Read the article

Get the latest in eczema news, delivered.

Sign up for NEA's e-newsletter to receive evidence-based articles, expert-sourced lifestyle tips and stories from your community.

About NEA
Press Room
Contact Us
Careers

Seal of Acceptance Application
Partnership Opportunities
Annual Report and 990

Privacy Policy
Terms and Conditions

The National Eczema Association (NEA) improves the health and quality of life for people affected by eczema, and empowers those who advocate, support and deliver care.

Our Accreditations

NEA is a qualified 501(c)(3) EIN 93-0988840.

© National Eczema Association, All rights reserved 2026

Filter Title

Search press release

Filter Title (0)

Currently showing 1 - 10 of 32 results

Sort By

Select an option

NEA Awards 9 Grants for Eczema Research

March 19, 2026

Eczema Re-listed as Eligible Condition for Department of Defense’s Peer-reviewed Medical Research Program for Fiscal Year 2025

November 05, 2025

New Research Finds Adults, Children and Teens with Eczema Experience Significant Mental Health Symptoms

March 27, 2025

New Research Finds Nearly 1 in 5 Adult Eczema Patients Have Multiple Eczema Conditions

March 17, 2025

Lorem ipsum dolor sit amet consectetur. Est tempor ultrices scelerisque

March 05, 2025

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard...

NEA Announces New Tower 28 Scholarship Fund to Support Patients and Caregivers Attending Eczema Expo

February 28, 2025

NEA Awards 9 New Grants for Eczema Research to New and Longstanding Investigators

February 27, 2025

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

December 13, 2024

Zug, Switzerland – December 13, 2024 – Galderma today announced that the United States (U.S.) Food and Drug Administration...

Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0310, a Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis

December 10, 2024

— Phase 1a Trial of STAR-0310 in Healthy Volunteers Expected to Initiate in Q1 2025 — — Early Proof-of-Concept...

FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema

September 24, 2024

September 23, 2024 06:00 AM Eastern Daylight Time MADISON, New Jersey–(BUSINESS WIRE)–NOT FOR UK USE – NOT INTENDED FOR...

1
2
3
4